Application 204854

Type
ANDA
Sponsor
DAEWOONG PHARM CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MEROPENEMMEROPENEMINJECTABLE;INJECTION500MG/VIALNoNo
002MEROPENEMMEROPENEMINJECTABLE;INJECTION1GM/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-155MeropenemmeropenemSagent PharmaceuticalsANDACurrent
25021-155MeropenemmeropenemSagent PharmaceuticalsANDACurrent
25021-156MeropenemmeropenemSagent PharmaceuticalsANDACurrent
25021-156MeropenemmeropenemSagent PharmaceuticalsANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-103MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent
70278-104MeropenemMeropenemDaewoong America Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
10403ORIG2015-12-22